Treatment of pulmonary hypertension in three patients with β-thalassemia intermedia using pulmonary arterial hypertension-specific medications

被引：2
|
作者：
Gerede, Demet Menekse [1 ]
Acibuca, Aynur [1 ]
Sayin, Tamer [1 ]
Erol, Cetin [1 ]
机构：
[1] Ankara Univ, Dept Cardiol, Fac Med, TR-06100 Ankara, Turkey
来源：
ANATOLIAN JOURNAL OF CARDIOLOGY | 2016年 / 16卷 / 01期
关键词：
THERAPY;
D O I：
10.14744/AnatolJCardiol.2015.6624
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：64 / 66
页数：4
相关论文
共 50 条
  • [1] Effectiveness and Outcome of Pulmonary Arterial Hypertension-Specific Therapy in Japanese Patients With Pulmonary Arterial Hypertension
    Tamura, Yuichi
    Kumamaru, Hiraku
    Satoh, Toru
    Miyata, Hiroaki
    Ogawa, Aiko
    Tanabe, Nobuhiro
    Hatano, Masaru
    Yao, Atsushi
    Abe, Kohtaro
    Tsujino, Ichizo
    Fukuda, Keiichi
    Kimura, Hiroshi
    Kuwana, Masataka
    Matsubara, Hiromi
    Tatsumi, Koichiro
    [J]. CIRCULATION JOURNAL, 2018, 82 (01) : 275 - U346
  • [2] Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension
    Anthi, Anastasia
    Tsangaris, Iraklis
    Hamodraka, Eftichia S.
    Lekakis, John
    Armaganidis, Apostolos
    Orfanos, Stylianos E.
    [J]. BLOOD, 2012, 120 (07) : 1531 - 1532
  • [3] A Review of Targeted Pulmonary Arterial Hypertension-Specific Pharmacotherapy
    Ataya, Ali
    Cope, Jessica
    Alnuaimat, Hassan
    [J]. JOURNAL OF CLINICAL MEDICINE, 2016, 5 (12):
  • [4] Pulmonary arterial hypertension-specific drugs - current status
    Staehler, G.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (40) : S183 - S186
  • [5] Use of pulmonary arterial hypertension-specific therapy in overweight or obese patients with obstructive sleep apnea and pulmonary hypertension
    Shujaat, Adil
    Bellardini, Jason
    Girdhar, Ankur
    Bajwa, Abubakr A.
    [J]. PULMONARY CIRCULATION, 2014, 4 (02) : 244 - 249
  • [6] Risk factors for pulmonary hypertension in patients with β thalassemia intermedia
    Karimi, Mehran
    Musallam, Khaled M.
    Cappellini, Maria Domenica
    Daar, Shahina
    El-Beshlawy, Amal
    Belhoul, Khawla
    Saned, Mohamed-SalahEldin
    Temraz, Sally
    Koussa, Suzanne
    Taher, Ali T.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2011, 22 (06) : 607 - 610
  • [7] Risk factors for pulmonary hypertension in patients with thalassemia intermedia
    Amoozgar, Hamid
    Farhani, Nahal
    Karimi, Mehran
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (06) : 549 - 551
  • [8] Use of Pulmonary Arterial Hypertension-Specific Therapy in Non-WHO Group I Pulmonary Hypertension
    Shujaat, Adil
    Bellardini, Jason
    Cury, James D.
    Bajwa, Abubakr A.
    [J]. SOUTHERN MEDICAL JOURNAL, 2015, 108 (01) : 51 - 57
  • [9] The effect of pulmonary arterial hypertension specific treatment on the left ventricle in patients with pulmonary arterial hypertension
    Mouratoglou, S. A.
    Wessels, J. N.
    Marcus, J. T.
    Meijboom, L. J.
    Handoko-De Man, E.
    Noordegraaf, A. Vonk
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 2300 - 2300
  • [10] Treatment of Pulmonary Hypertension Caused by Left Heart Failure With Pulmonary Arterial Hypertension-Specific Therapies Lessons From the Right and LEPHT
    Rubin, Lewis J.
    [J]. CIRCULATION, 2013, 128 (05) : 475 - 476
12345